Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:

feasibility, safety, efficacy [ Time Frame: 1 yr ]

Study Start Date:

January 2007

Estimated Study Completion Date:

December 2007

Intervention Details:

Biological: Stem cell therapy

Injection of a hematopoietic stem cell suspension (50'000 CD 34+ cells per microliter) into the wound (1 microliter per cm2 of wound surface)

Eligibility

Ages Eligible for Study:

18 Years to 50 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Para- or tetraplegic

Sacral pressure sores

Grade III-IV according to classification of Daniel and Seiler

Exclusion Criteria:

Diabetes mellitus

Peripheral vascular disease

Coronary artery disease

Smoking

Steroids and other immunosuppressive drugs

Systemic autoimmune or rheumatoid diseases

HIV

Hepatitis B/C

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00535548